Fig. 3From: Chidamide increases the sensitivity of refractory or relapsed acute myeloid leukemia cells to anthracyclines via regulation of the HDAC3 -AKT-P21-CDK2 signaling pathwayHigh expression levels of HDAC3 are associated with poorer prognoses. a OS and (b) EFS in the primary cohort of 163 AML patients. Multivariable analysis of HDAC3 expression associated with OS(c) and EFS (d)Back to article page